Knowledge of HPV-Related Oropharyngeal Cancer and Use of Human Papillomavirus Vaccines by Pediatricians in Louisiana

Vikas Mehta, MD, MPH, FACS; Sean Holmes, MD; Adam Master, MD; Blake Leblanc, MD; L. Gloria Caldito, PhD; Joseph Bocchini, Jr., MD; Cherie-Ann Nathan, MD, FACS



To determine the level of knowledge of HPV related oropharyngeal cancer and practice patterns of HPV vaccine use by pediatricians.


IRB approved 18-question survey was administered to members of the Louisiana Chapter of the American Academy of Pediatrics. 


We received 116 responses (response rate: 15.9%). 104 respondents (89.66%) routinely recommend/offer HPV vaccine, 6 (5.17%) occasionally or only at caregiver request, and 6 (5.17%) do not offer the vaccine. 17 (15.5%) reported having no awareness of the link between oropharyngeal cancer and HPV, and only 50 (45.9%) had knowledge that HPV-related oropharyngeal cancer incidence was increasing. Strength of recommendation for males and knowledge of HPV-related oropharyngeal cancer were not associated with years in practice, practice type or patient population served.


Increased awareness regarding HPV-related oropharyngeal cancers among primary care providers may increase HPV immunization rates, especially in males.


Log in to read full article.

Member Login